ExxonMobil Commits $5.7MM to Fight Malaria



ExxonMobil Commits $5.7MM to Fight Malaria
ExxonMobil is committing $5.7 million in support for local and global organizations working to eliminate malaria around the world.

ExxonMobil revealed Thursday that it is committing $5.7 million in support for local and global organizations working to eliminate malaria around the world.

The donation recipients include:

  • ADPP Angola
  • Africare
  • Baylor College of Medicine
  • Corporate Alliance on Malaria in Africa (CAMA)
  • Friends of the Global Fight
  • Grassroot Soccer
  • Harvard T.H. Chan School of Public Health
  • Jhpiego, Malaria No More
  • PATH Malaria Vaccine Initiative
  • Seed Global Health
  • Special Olympics
  • Tchova Tchova
  • ExxonMobil Global Health Scholars at the University of Oxford
  • Worldwide Antimalarial Resistance Network (WWARN).

Since 2000, ExxonMobil has invested a total of $170 million, supporting the delivery of 15 million bed nets to prevent mosquito bites, the administration of five million antimalarial treatments and the distribution of 3.9 million rapid diagnostic kits. The company has also supported the training of 700,000 health workers.

“We focus our attention on local and global organizations that deliver health services and supplies directly to affected communities,” Kevin Murphy, president of the ExxonMobil Foundation, said in an organization statement.

“While great progress continues to be made in saving lives from malaria around the world, important work remains to prevent the disease’s resurgence,” he added.

Last month, the company said it was providing $300,000 to aid agencies to support disaster relief and recovery efforts in Mozambique following Cyclone Idai. During the same month, ExxonMobil said it will provide about $5 million in grants to support local and global organizations dedicated to empowering women economically.



WHAT DO YOU THINK?


Generated by readers, the comments included herein do not reflect the views and opinions of Rigzone. All comments are subject to editorial review. Off-topic, inappropriate or insulting comments will be removed.